Cost‐Effectiveness of Hypoglossal Nerve Stimulation for Pediatric Severe Obstructive Sleep Apnea in Down Syndrome Patients
The current study suggests HGNS is a cost-effective treatment strategy for pediatric patients with DS and severe OSA. Our findings also suggest cost-effectiveness at ages younger than 13, the current age of FDA approval.
Authors
- Patrick Scheffler (ORCID: https://orcid.org/0009-0008-7659-3945)
- Frances M. Nowlen
Institutions
- Creighton University (US)
- Cohen Children's Medical Center (US)
- Phoenix Children's Hospital (US)
Publication Details
- Journal
- Otolaryngology
- Published
- 2024-10-26
- DOI
- https://doi.org/10.1002/ohn.1030
- Citations
- 1
- Primary Topic
- Obstructive Sleep Apnea Research
- Type
- article
- Field-Weighted Citation Impact
- 0.33